US › Healthcare

XWELL Inc. (XWEL)

US · Healthcare · Diagnostics & Research

$1.04-4.59%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$6.6M

Revenue YoY

-5.5%

Net profit

$-11.2M

Profit YoY

-136.9%

EPS

$-1.51

Net margin

-168.4%

Key statistics

Market cap

$9.2M

Forward P/E

10.8

P/B

21.48

Book value

$0.05

EPS (TTM)

$-5.59

52-week high

$2.20

52-week low

$0.26

50-day MA

$1.15

200-day MA

$0.97

Beta

1.01

Analyst view

Analysts rate XWELL Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.00.

Shareholding

Insiders

18.48%

Institutions

14.76%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	0.97%
BlackRock Inc	0.97%
Geode Capital Management, LLC	0.80%
Vanguard Capital Management, LLC	0.61%
Vanguard Fiduciary Trust Co	0.28%
Morgan Stanley - Brokerage Accounts	0.26%
State Street Corp	0.19%
UBS Group AG	0.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for XWELL Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.